Fund Holdings — ORACLE INVESTMENT MANAGEMENT INC

Total Portfolio Value:
$153.60M
Total Bought:
$20.93M
Total Sold:
$29.00M
Net Transaction:
-$8.07M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
GeneDx Holdings Corp.CL A(WGS)1,023,468969,954-53,514$78.66M$85.90M55.93%+$7.24M
Springworks Therapeutics Inc254,773531,351+276,578$9.20M$23.45M15.27%+$14.24M
Biohaven Ltd.(BHVN)851,770665,945-185,825$31.81M$16.01M10.42%-$15.80M
Ardelyx Inc2,089,4312,404,438+315,007$10.59M$11.81M7.69%+$1.21M
Teladoc Health, Inc.(TDOC)0565,900+565,900$0$4.50M2.93%+$4.50M
QuidelOrtho Corporation(QDEL)118,291118,2910$5.27M$4.14M2.69%-$1.13M
Forian Inc
COM
1,366,1071,366,1070$2.81M$2.73M1.78%-$82.0K
Palantir Technologies Inc.CL A(PLTR)28,50029,500+1,000$2.16M$2.49M1.62%+$334.3K
CAVA Group, Inc.(CAVA)18,60018,6000$2.10M$1.61M1.05%-$490.9K
Recursion Pharmaceuticals, Inc.CL A(RXRX)0120,000+120,000$0$634.8K0.41%+$634.8K
Biogen Inc.(BIIB)2,4122,4120$368.8K$330.1K0.21%-$38.8K
BioCryst Pharmaceuticals, Inc.(BCRX)535,5580-535,558$4.03M$0—-$4.03M
EyePoint, Inc.(EYPT)32,5000-32,500$242.1K$0—-$242.1K
Pacific Biosciences of California, Inc.(PACB)279,6380-279,638$511.7K$0—-$511.7K
Phathom Pharmaceuticals, Inc.(PHAT)145,0640-145,064$1.18M$0—-$1.18M
Page 1 of 1
ORACLE INVESTMENT MANAGEMENT INC — 13F Holdings — Q1 2025 | TickerTrail